Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $179.43 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.58 | 3 | $0 (2021) |
| ABBVIE INC. | $41.28 | 2 | $0 (2022) |
| Amgen Inc. | $25.04 | 1 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $20.88 | 1 | $0 (2023) |
| Abbott Laboratories | $18.69 | 1 | $0 (2021) |
| Lilly USA, LLC | $16.95 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13.01 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.95 | 1 | Lilly USA, LLC ($16.95) |
| 2023 | $20.88 | 1 | Supernus Pharmaceuticals, Inc. ($20.88) |
| 2022 | $41.28 | 2 | ABBVIE INC. ($41.28) |
| 2021 | $100.32 | 6 | NOVARTIS PHARMACEUTICALS CORPORATION ($43.58) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes | ||||||
| 08/21/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Neuromodulation | ||||||
| 05/06/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Neuroscience | ||||||
| 03/11/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 01/07/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: NEUROSCIENCE | ||||||
About Chris Lavers, PA-C
Chris Lavers, PA-C is a Medical healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891862082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chris Lavers, PA-C has received a total of $179.43 in payments from pharmaceutical and medical device companies, with $16.95 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($179.43).
Practice Information
- Specialty Medical
- Other Specialties Dermatology
- Location Bartlesville, OK
- Active Since 11/30/2006
- Last Updated 09/11/2014
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1891862082
Products in Payments
- AIMOVIG (Biological) $43.58
- VRAYLAR (Drug) $41.28
- Aimovig (Biological) $25.04
- XYOSTED (Drug) $20.88
- Proclaim IPG (Device) $18.69
- MOUNJARO (Drug) $16.95
- FARXIGA (Drug) $13.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.